$0.515
-0.021 (-4.15%)收盤時
- 最高
- 0.537
- 開盤
- 0.537
- 成交量加權均價
- 0.52
- 成交量
- 24.47K
- 市值
- 7.04M
- 最低
- 0.515
- 成交金額
- 12.79K
- 企業價值/稅息折舊攤銷前利潤(TTM)
- 0.00
Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.
AI 分析 of Amesite Inc (AMST)
賣出Amesite Inc is not a good buy right now due to its extremely low Relative Strength Index (RSI) of 11.041, indicating it is oversold, and a staggering year-to-date change of -74.25%, reflecting significant declines in its stock price. The company's financials show consistent net losses, with the latest EPS reported at -0.14 and a forward P/E ratio of 0, suggesting no expected profitability in the near future. The main risk is the substantial decline in stock value, with a 52-week low of 0.52, which indicates a lack of investor confidence and potential for further losses.
估值指標
事件時間軸
資訊
7.505-19seekingalphaAmesite Secures Largest Enterprise Customer, Shares Surge
7.505-18NewsfilterAmesite Secures Largest Enterprise Customer, Validating Strategic Success
8.504-28NewsfilterAmesite Closes Private Placement of 696,866 Shares
8.504-27NewsfilterAmesite Inc. Completes Sale of 696,866 Shares in Direct Offering
8.504-27NewsfilterAmesite Withdraws Public Offering Registration Statement
AMST 常見問題 —— 由 Alphio AI 解答
Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).
Amesite Inc is not a good buy right now due to its extremely low Relative Strength Index (RSI) of 11.041, indicating it is oversold, and a staggering year-to-date change of -74.25%, reflecting significant declines in its stock price. The company's financials show consistent net losses, with the latest EPS reported at -0.14 and a forward P/E ratio of 0, suggesting no expected profitability in the near future. The main risk is the substantial decline in stock value, with a 52-week low of 0.52, which indicates a lack of investor confidence and potential for further losses.
社群
更多 ↗暫無貼文
註冊或登入後參與討論相關文章
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。